Physician

Jatinder Kajla, M.D.

According to 2025 Medicare claims, Jatinder Kajla, M.D. (NPI: 1629337449) practices emergency medicine in the Yuba City, CA market, with the plurality of this provider's patient population coming from Yuba, CA. This provider's primary affiliated billing organization is JATINDER KAJLA MD INC (NPI: 1881483675) and primary practice location at 95834-2480.

Kajla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 742 traditional Medicare patients, billed 885 HCPCS/CPT codes, and received $95,377 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 423 prescription claims across 302 beneficiaries totaling $5,167 in drug costs, led by Albuterol Sulfate Hfa (Albuterol Sulfate). Open Payments data shows 4 records totaling $75. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $39,353 and ending at $95,377. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,133 to $5,167. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$52K$105K2015 Medicare payment: $39,353 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $82,263 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $104,505 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $66,583 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $42,895 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $49,842 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $75,695 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $92,266 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $93,792 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $95,377 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015322348$39,353
2016676767$82,263
2017795919$104,505
2018554637$66,583
2019380450$42,895
2020385436$49,842
2021549617$75,695
2022669761$92,266
2023721806$93,792
2024742885$95,377

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$4.2K$8.3K2015 Drug cost: $1,133 (USD; Tot_Drug_Cst)2016 Drug cost: $2,518 (USD; Tot_Drug_Cst)2017 Drug cost: $3,465 (USD; Tot_Drug_Cst)2018 Drug cost: $2,478 (USD; Tot_Drug_Cst)2019 Drug cost: $3,342 (USD; Tot_Drug_Cst)2020 Drug cost: $3,298 (USD; Tot_Drug_Cst)2021 Drug cost: $3,830 (USD; Tot_Drug_Cst)2022 Drug cost: $6,014 (USD; Tot_Drug_Cst)2023 Drug cost: $8,320 (USD; Tot_Drug_Cst)2024 Drug cost: $5,167 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157787$1,133
2016182243$2,518
2017222302$3,465
2018140179$2,478
2019173241$3,342
2020138187$3,298
2021158230$3,830
2022231299$6,014
2023252349$8,320
2024302423$5,167

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99291Critical care, first 30-74 minutes5154$165
99285Emergency department visit with high level of medical decision making438456$132
99284Emergency department visit with moderate level of medical decision making213218$91
99283Emergency department visit with low level of medical decision making4647$52
93010Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only4950$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Albuterol Sulfate HfaAlbuterol Sulfate23551$572
CephalexinCephalexin63462$409
Ondansetron OdtOndansetron40149$385
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst32168$314
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26105$171

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$75ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jatinder Kajla, M.D.?

Tedicare shows public-source Medicare data for Jatinder Kajla, M.D. (NPI 1629337449), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jatinder Kajla, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jatinder Kajla, M.D.?

Jatinder Kajla, M.D. is linked to JATINDER KAJLA MD INC (billing NPI 1881483675) in the available physician profile data.

Does Jatinder Kajla, M.D. have Open Payments data?

Jatinder Kajla, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.